Clinical Trial Update: Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia [Phase 2]

View source ↗

Summary

A multicenter Phase 2 trial evaluating decitabine for chronic myelomonocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelomonocytic Leukemia

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: Fondazione Italiana Sindromi Mielodisplastiche-ETS | Conditions: Chronic Myelomonocytic Leukemia | Phase 2 | Status: COMPLETED